Currently, people need to undergo different screening methods for each type of cancer. This process can be invasive, emotionally stressful, and expensive. Because patients find testing to be stressful and costly, they are not testing early enough making their cancer more difficult to treat.
PFM is developing a single blood test that can detect multiple cancer types at earlier stages. This service is coupled with deep learning technology that enables higher accuracy in early stage detection. This AI-powered technology identifies specific compounds in the blood to detect cancer-associated patterns. PFM aims to increase the accessibility and success rate of earlier cancer detection, resulting in immediate treatment worldwide.
Nobuhiro Andrew Kawai (Andy)
Healthcare Service Business Unit
An interview with MetaJob founder Nao Hoshino about his inspiration and experiments creating a more human-centered future of work.Read More
Interview with Moon Creative Lab’s Chief Creative Officer, Mike Peng, to learn more about the vision of Moon Media and what’s to come.Read More